Cf. Wu et al., DL-FENFLURAMINE INHIBITS ETHANOL-INDUCED ASCORBIC-ACID RELEASE IN RATSTRIATUM STUDIED BY MICRODIALYSIS, Addiction biology, 3(3), 1998, pp. 295-308
The effects of dl-fenfluramine, dl-5-hydroxytryptophan(5-HTP) and fluo
xetine on ethanol-induced striatal ascorbic acid (AA) release in rat w
ere studied by microdialysis coupled to high performance liquid chroma
tography with electrochemical detection. Ethanol (3.0 g/kg, i.p) stimu
lated striatal AA release to more than 200% above the baseline, dl-Fen
fluramine (20 mg/kg, i.p. or 40 mu g/rat, i.c.v.), 10 min before ethan
ol administration, markedly inhibited ethanol-induced AA release. A si
milar result was also observed following dl-5-HTP (100 mg/kg, i.p.) ad
ministration. However, fluoxetine (10, 30 mg/kg, i.p.) showed no antag
onistic effect on ethanol-induced AA release. The suppressing effect o
f dl-fenfluramine and dl-5-HTP on ethanol-induced AA release could be
reversed by the 5-HT receptor antagonist cyproheptadine (10 mg/kg, s.c
.). All these drugs had no effect on basal AA release. The results giv
e a first evidence for the involvement of central serotonergic system,
and suggest that differential activities may exist between dl-fenflur
amine, dl-5-HTP and fluoxetine in regulating ethanol-induced AA releas
e in rat striatum.